BioCorRx director Kate Beebe DeVarney resigns from board effective Aug 31, 2026

BioCorRx Inc.

Kate Beebe DeVarney, Ph.D. resigned from BioCorRx board effective August 31, 2026.
Resignation not due to any disagreement with company or subsidiary BioCorRx Pharmaceuticals.
No replacement named in filing; board size reduced accordingly.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kate Beebe DeVarney

member of the board of directors

BICX · BioCorRx Inc.

Effective: 2026-08-31
Filed: September 4, 2026, 9:53 AM ET

On August 31, 2026, Kate Beebe DeVarney, Ph.D. submitted her resignation from her position as a member of the board of directors (the “Board”) of BioCorRx Inc.(the “Company”), effective August 31, 2026 (the “DeVarney Resignation”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kate Beebe DeVarney resigned as member of the board of directors at BioCorRx Inc..

Action: resigned
Role: member of the board of directors

Exact text from the filing

On August 31, 2026, Kate Beebe DeVarney, Ph.D. submitted her resignation from her position as a member of the board of directors (the “Board”) of BioCorRx Inc.(the “Company”), effective August 31, 2026 (the “DeVarney Resignation”).

View on SEC.gov

BioCorRx Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-005416

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.